-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Ptc Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2023.
- Ptc Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $8.66M.
- Ptc Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $27.7M.
- Ptc Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$69.5M, a 144% decline from 2022.
- Ptc Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$28.5M, a 612% decline from 2021.
- Ptc Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $5.56M, a 84.2% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)